The rushed emergency approval for a treatment that might help COVID-19 patients has raised questions: Is the FDA abandoning its own guidelines?
Academic rigour, journalistic flair
Articles on Emergency Use Authorization
Displaying 21 - 22 of 22 articles
Testing for coronavirus has been a fiasco in the US. But now companies are developing super fast tests, including ones that might eventually be as simple as at home pregnancy tests.
Top contributors
-
Professor of Medicine, University of Virginia
-
Professor of Law, Villanova School of Law
-
Associate Professor of Public Policy, University of Maryland, Baltimore County
-
Shah Rising Star Assistant Professor of Chemical Engineering, Herbert Wertheim College of Engineering, UF Health Cancer Center, University of Florida
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Professor of Law, University of Maryland
-
Instructor of Human Immunology, Emory University
-
Professor of Biostatistics, University of Arizona
-
Assistant Professor of Epidemiology and Biostatistics, University of Arizona
-
Professor of Medicine, Johns Hopkins University
-
Associate Dean and Professor of Pharmacy, University of California, San Francisco
-
Professor of Law, Saint Louis University
-
Charles Stewart Mott Endowed Professor of Public Health and an Associate Professor of Pediatrics and Human Development at the Michigan State University College of Human Medicine, Michigan State University
